Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Australian Securities Exchange (ASX) is Australia's primary securities exchange and one of the world's leading financial market operators. While not a biotechnology or healthcare company itself, the ASX serves as a critical global hub for the life sciences sector, hosting one of the largest ecosystems of listed healthcare and biotech companies in the Asia-Pacific region. The exchange provides a multi-asset class marketplace including equities, derivatives, and fixed-income products, alongside essential services such as listing, trading, clearing, and settlement. For biotech analysts, the ASX is significant as a primary venue for capital raising and liquidity for both early-stage drug development firms and established medical device manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Australian Securities Exchange.